Clinical Trial Update: Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer; the study has completed and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• Topotecan (topotecan)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-07-28